Xylem Inc. (NYSE:XYL) shares hit a new 52-week high on Wednesday . The stock traded as high as $48.02 and last traded at $47.60, with a volume of 253,413 shares. The stock had previously closed at $47.78.

Several research analysts have commented on XYL shares. Barclays PLC raised their price objective on Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research report on Monday, July 18th. Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $52.00 target price (up from $46.00) on shares of Xylem in a research report on Monday, June 20th. Royal Bank Of Canada raised Xylem from a “sector perform” rating to an “outperform” rating and lifted their target price for the stock from $37.00 to $42.00 in a research report on Wednesday, June 1st. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $42.00 target price on shares of Xylem in a research report on Wednesday, May 4th. Nine equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Xylem has an average rating of “Hold” and an average price target of $42.25.

The company’s 50-day moving average is $46.01 and its 200-day moving average is $41.28. The company has a market cap of $8.51 billion and a price-to-earnings ratio of 25.14.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, May 3rd. The company reported $0.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.34 by $0.01. The company had revenue of $847 million for the quarter, compared to the consensus estimate of $832.03 million. Xylem’s revenue for the quarter was up 1.2% compared to the same quarter last year. During the same period last year, the company earned $0.33 earnings per share. On average, equities analysts predict that Xylem Inc. will post $2.05 earnings per share for the current year.

In related news, Director Steven R. Loranger sold 50,000 shares of the stock in a transaction that occurred on Friday, May 27th. The shares were sold at an average price of $44.67, for a total value of $2,233,500.00. Following the transaction, the director now directly owns 12,588 shares in the company, valued at $562,305.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Kenneth Napolitano sold 10,246 shares of the stock in a transaction that occurred on Thursday, May 5th. The shares were sold at an average price of $41.58, for a total transaction of $426,028.68. Following the completion of the transaction, the senior vice president now owns 44,409 shares in the company, valued at $1,846,526.22. The disclosure for this sale can be found here.

Other institutional investors have made changes to their positions in the company. GAM Holding AG raised its position in shares of Xylem by 4.6% in the fourth quarter. GAM Holding AG now owns 31,899 shares of the company’s stock valued at $1,164,000 after buying an additional 1,412 shares in the last quarter. Utah Retirement Systems raised its position in shares of Xylem by 0.3% in the fourth quarter. Utah Retirement Systems now owns 32,465 shares of the company’s stock valued at $1,185,000 after buying an additional 100 shares in the last quarter. Aberdeen Asset Management PLC UK raised its position in shares of Xylem by 24.9% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 35,358 shares of the company’s stock valued at $1,259,000 after buying an additional 7,040 shares in the last quarter. Comerica Bank raised its position in shares of Xylem by 1.8% in the fourth quarter. Comerica Bank now owns 43,551 shares of the company’s stock valued at $1,497,000 after buying an additional 774 shares in the last quarter. Finally, Nationwide Fund Advisors raised its position in shares of Xylem by 11.9% in the fourth quarter. Nationwide Fund Advisors now owns 60,233 shares of the company’s stock valued at $2,199,000 after buying an additional 6,417 shares in the last quarter.

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.